Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Pharma
Analysts see M&A surge on the horizon in 2025
Reductions in staff at the FDA are putting pressure on biotechs, especially those strapped for cash, and could lead to more M&A activity.
Kevin Dunleavy
May 1, 2025 3:45pm
Sanofi sells controlling stake of consumer health unit for €10B
Apr 30, 2025 10:59am
PCI continues expansion tear with Ajinomoto Althea acquisition
Apr 28, 2025 3:10pm
Merck KGaA jumps back into M&A game with $3.9B SpringWorks buyout
Apr 28, 2025 11:09am
Meribel makes CDMO debut after series of acquisitions in Europe
Apr 21, 2025 11:26am
Ligand's Pelthos unit merges with Channel to launch Zelsuvmi
Apr 17, 2025 5:00pm
